We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Lunglife Ai Inc | LLAI | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
9.75 | 9.75 | 10.25 | 10.25 | 9.75 |
Industry Sector |
---|
PHARMACEUTICALS & BIOTECHNOLOGY |
Top Posts |
---|
Posted at 22/1/2025 10:47 by findingways100 wish you told me about exr yesterday |
Posted at 22/1/2025 10:45 by tomboyb There are not too many AI stocks out there-Today took a stake in EXR - LLAI went nutx a while back from 20p and smashed to around 130p - However the point is look for ai stocks for portfolio - |
Posted at 02/1/2024 08:25 by brummy_git LungLife's patented Circulating Tumour Cell blood test (LungLB) successfully passes its pivotal 425 person, 17 site, validation study (commenced Feb’22) with flying colours.All the details here. |
Posted at 20/12/2023 17:23 by donk7 Birmingham, has your pal Justin been knocking these out recently? Justin is an impressive small-cap stock picker but incredibly opaque regarding his buys, sells and trading intentions. I'm not sure that is the right way for someone who promotes his often illiquid stocks so forcefully. You can't get much more illiquid than LLAI.The issue with LungLife is that they will need to raise funds. That's no secret. It's not an easy market to do that and I'd assume those willing to fund will only want to come in before results rather than after a potential decent rise post positive results. No guarantees the results will be good but I'd imagine they would be decent. So my guess is a placing followed by results. I don't hold as it is too illiquid but it's one to watch. If they do a placing then hopefully that will make it less liquid. |
Posted at 21/8/2023 17:02 by hatfullofsky Justin Waite is pumping LLAIhttps://youtu.be |
Posted at 08/8/2023 06:06 by brummy_git The momentum is building at next generation lung cancer diagnostics firm LungLife AI.Find out all the details here wrt today's 'in line' H1 results. |
Posted at 06/6/2023 07:04 by brummy_git Further positive & independently peer-reviewed medical data released today by cutting edge, lung cancer diagnostics firm LungLife AIAll the details here. |
Posted at 26/11/2022 07:20 by brummy_git Lunglife AI talked about hereVerici mentioned here www.linkedin.com/pos |
Posted at 26/9/2022 07:35 by brummy_git Marvellous comments here from LungLife AI CEO Paul Pagano wrt today's positive H1 results & outlook.www.linkedin.com/pos www.linkedin.com/pos |
Posted at 28/3/2022 06:13 by brummy_git Steady as she goes at innovative, early-stage lung cancer diagnostics firm LungLife AI (re prelims).Find out all the news & commentary here. www.linkedin.com/pos |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions